# A Study of MK-6598 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-6598-001)

> clinical trial · VERIFIED · 2026-07-15

Status: COMPLETED · Sponsor: Merck Sharp & Dohme LLC · Condition: Advanced or Metastatic Solid Tumors

- Company: Merck Sharp & Dohme LLC
- Sector: Advanced or Metastatic Solid Tumors
- Primary source: https://clinicaltrials.gov/study/NCT05594043

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.